NAIOP New Jersey has announced seven finalists for its coveted Deal of the Year honors, with plans to unveil the winners at its annual awards gala slated for early October.
New Jersey needs turnkey lab space, faster approvals to compete for life sciences users
Experts say New Jersey faces a growing challenge: While it’s still a major draw for pharmaceutical research and development, speed to market has become increasingly important to life sciences users. That means the state’s lack of move-in-ready lab space — and its lengthy approval process for new construction — puts it at a disadvantage to competing markets.
